| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 805 | 1.613 | 2.158 | 710 | 4.525 | 10.576 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 805 | 1.613 | 2.158 | 710 | 4.525 | 10.576 |
| Total Expenses - EUR | 16 | 13 | 13 | 20 | 14 | 12 | 2.261 | 5.101 | 9.440 | 9.636 |
| Gross Profit/Loss - EUR | -16 | -13 | -13 | -20 | 790 | 1.601 | -103 | -4.391 | -4.915 | 940 |
| Net Profit/Loss - EUR | -16 | -13 | -13 | -20 | 766 | 1.555 | -168 | -4.405 | -4.954 | 834 |
| Employees | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Biodin Almi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.382 | 7.290 | 7.167 | 7.019 | 7.672 | 9.061 | 8.699 | 4.320 | 9.877 | 4.810 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.524 | 6.458 | 6.348 | 6.232 | 6.111 | 8.269 | 8.086 | 3.447 | 3.530 | 161 |
| Cash | 858 | 832 | 818 | 787 | 1.561 | 791 | 613 | 873 | 6.348 | 4.649 |
| Shareholders Funds | 7.382 | 7.290 | 7.167 | 7.019 | 7.649 | 9.059 | 8.690 | 4.312 | -655 | 183 |
| Social Capital | 675 | 668 | 657 | 645 | 632 | 620 | 606 | 608 | 606 | 603 |
| Debts | 0 | 0 | 0 | 0 | 23 | 2 | 8 | 8 | 10.533 | 4.627 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5811 - 5811" | |||||||||
| CAEN Financial Year |
5811
|
|||||||||
Comments - Biodin Almi Srl